Q9JLB4 (CUBN_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 98.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Cubilin Alternative name(s): Intrinsic factor-cobalamin receptor | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 3623 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cotransporter which plays a role in lipoprotein, vitamin and iron metabolism, by facilitating their uptake. Binds to ALB, MB, Kappa and lambda-light chains, TF, hemoglobin, GC, SCGB1A1, APOA1, high density lipoprotein, and the GIF-cobalamin complex. The binding of all ligands requires calcium. Serves as important transporter in several absorptive epithelia, including intestine, renal proximal tubules and embryonic yolk sac. Interaction with LRP2 mediates its trafficking throughout vesicles and facilitates the uptake of specific ligands like GC, hemoglobin, ALB, TF and SCGB1A1. Interaction with AMN controls its trafficking to the plasma membrane and facilitates endocytosis of ligands. May play an important role in the development of the peri-implantation embryo through internalization of APOA1 and cholesterol. Binds to LGALS3 at the maternal-fetal interface. Ref.2 Ref.3 Ref.4 Ref.6 |
| Subunit structure | Interacts with LRP2 in a dual-receptor complex in a calcium-dependent manner By similarity. Component of the cubam complex composed of CUBN and AMN. The cubam complex can oligomerize and form cubam trimers. Found in a complex with PID1/PCLI1, LRP1 and CUBNI By similarity. Interacts with LRP1 and PID1/PCLI1 By similarity. Ref.2 Ref.3 Ref.4 Ref.6 |
| Subcellular location | Endosome membrane; Peripheral membrane protein By similarity. Lysosome membrane; Peripheral membrane protein By similarity. Note: Colocalizes with AMN and LRP2 in the endocytotic apparatus of epithelial cells By similarity. |
| Tissue specificity | Expressed in kidney, thymus, ileum, placenta, small intestine and yolk sac. In kidney expressed on the apical brush border surface of proximal tubular cells, in particular in endosomes and recycling membranes vesicles, so-called dense apical tubules, which carry internalized receptors back to the cell surface. Expressed in fetal membranes of yolk sac, placenta of pregnant females. Ref.2 Ref.3 |
| Developmental stage | Detected in yolk sac endoderm as early as day 6 and is present at the apical surface of those cells throughout the remainder of pregnancy. Apical expression is pronounced in the extraembryonic visceral endoderm (VE) of 6-9.5 dpc. Expressed by a subpopulation of cells dispersed within the 7.5 dpc embryonic endoderm and having a migratory morphology. First detected at the eight-cell stage. At the 32-cell stage expressed in all outer cells which are at the origin of the trophectoderm (TE). During the blastocyst stage, expression is predominant at the apical membrane of the TE cells. Ref.2 Ref.5 Ref.7 |
| Domain | The CUB domains 5 to 8 mediate binding to GIF and ALB. CUB domains 1 and 2 mediate interaction with LRP2 By similarity. |
| Post-translational modification | The precursor is cleaved by a trans-Golgi proteinase furin. The result is a propeptide cleaved off By similarity. N-glycosylated. Ref.2 |
| Sequence similarities | Contains 27 CUB domains. Contains 7 EGF-like domains. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 20 | 20 | Potential | ||||||||
| Propeptide | 21 – 32 | 12 | Removed in mature form By similarity | PRO_0000046074 | |||||||
| Chain | 33 – 3623 | 3591 | Cubilin | PRO_0000046075 | |||||||
Regions | |||||||||||
| Domain | 129 – 165 | 37 | EGF-like 1 | ||||||||
| Domain | 167 – 208 | 42 | EGF-like 2; calcium-binding Potential | ||||||||
| Domain | 260 – 301 | 42 | EGF-like 3; calcium-binding Potential | ||||||||
| Domain | 302 – 345 | 44 | EGF-like 4; calcium-binding Potential | ||||||||
| Domain | 346 – 385 | 40 | EGF-like 5 | ||||||||
| Domain | 395 – 430 | 36 | EGF-like 6 | ||||||||
| Domain | 432 – 468 | 37 | EGF-like 7; calcium-binding Potential | ||||||||
| Domain | 474 – 586 | 113 | CUB 1 | ||||||||
| Domain | 590 – 702 | 113 | CUB 2 | ||||||||
| Domain | 708 – 816 | 109 | CUB 3 | ||||||||
| Domain | 817 – 928 | 112 | CUB 4 | ||||||||
| Domain | 932 – 1042 | 111 | CUB 5 | ||||||||
| Domain | 1048 – 1161 | 114 | CUB 6 | ||||||||
| Domain | 1165 – 1277 | 113 | CUB 7 | ||||||||
| Domain | 1278 – 1389 | 112 | CUB 8 | ||||||||
| Domain | 1391 – 1506 | 116 | CUB 9 | ||||||||
| Domain | 1510 – 1619 | 110 | CUB 10 | ||||||||
| Domain | 1620 – 1734 | 115 | CUB 11 | ||||||||
| Domain | 1738 – 1850 | 113 | CUB 12 | ||||||||
| Domain | 1852 – 1963 | 112 | CUB 13 | ||||||||
| Domain | 1978 – 2091 | 114 | CUB 14 | ||||||||
| Domain | 2092 – 2213 | 122 | CUB 15 | ||||||||
| Domain | 2217 – 2334 | 118 | CUB 16 | ||||||||
| Domain | 2336 – 2448 | 113 | CUB 17 | ||||||||
| Domain | 2452 – 2565 | 114 | CUB 18 | ||||||||
| Domain | 2570 – 2687 | 118 | CUB 19 | ||||||||
| Domain | 2689 – 2801 | 113 | CUB 20 | ||||||||
| Domain | 2805 – 2919 | 115 | CUB 21 | ||||||||
| Domain | 2920 – 3035 | 116 | CUB 22 | ||||||||
| Domain | 3037 – 3150 | 114 | CUB 23 | ||||||||
| Domain | 3157 – 3274 | 118 | CUB 24 | ||||||||
| Domain | 3278 – 3393 | 116 | CUB 25 | ||||||||
| Domain | 3395 – 3507 | 113 | CUB 26 | ||||||||
| Domain | 3511 – 3623 | 113 | CUB 27 | ||||||||
Sites | |||||||||||
| Metal binding | 980 | 1 | Calcium 1 By similarity | ||||||||
| Metal binding | 988 | 1 | Calcium 1 By similarity | ||||||||
| Metal binding | 1027 | 1 | Calcium 1 By similarity | ||||||||
| Metal binding | 1030 | 1 | Calcium 1; via carbonyl oxygen By similarity | ||||||||
| Metal binding | 1096 | 1 | Calcium 2 By similarity | ||||||||
| Metal binding | 1105 | 1 | Calcium 2 By similarity | ||||||||
| Metal binding | 1146 | 1 | Calcium 2 By similarity | ||||||||
| Metal binding | 1213 | 1 | Calcium 3 By similarity | ||||||||
| Metal binding | 1221 | 1 | Calcium 3 By similarity | ||||||||
| Metal binding | 1262 | 1 | Calcium 3 By similarity | ||||||||
| Metal binding | 1264 | 1 | Calcium 3; via carbonyl oxygen By similarity | ||||||||
| Metal binding | 1265 | 1 | Calcium 3; via carbonyl oxygen By similarity | ||||||||
| Metal binding | 1328 | 1 | Calcium 4 By similarity | ||||||||
| Metal binding | 1336 | 1 | Calcium 4 By similarity | ||||||||
| Metal binding | 1373 | 1 | Calcium 4 By similarity | ||||||||
| Metal binding | 1375 | 1 | Calcium 4; via carbonyl oxygen By similarity | ||||||||
| Site | 32 – 33 | 2 | Cleavage; by furin Potential | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 95 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 428 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 491 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 711 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 749 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 781 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 857 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 957 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1043 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1168 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1217 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1285 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1307 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1319 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1332 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1500 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1551 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1646 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1802 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1819 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1967 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2085 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 2117 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2274 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2400 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2531 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2581 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2610 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2813 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2925 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 2989 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3106 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3125 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 3268 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3283 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3290 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3357 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3457 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3533 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 133 ↔ 144 | By similarity | |||||||||
| Disulfide bond | 138 ↔ 153 | By similarity | |||||||||
| Disulfide bond | 155 ↔ 164 | By similarity | |||||||||
| Disulfide bond | 171 ↔ 187 | By similarity | |||||||||
| Disulfide bond | 181 ↔ 196 | By similarity | |||||||||
| Disulfide bond | 198 ↔ 207 | By similarity | |||||||||
| Disulfide bond | 264 ↔ 277 | By similarity | |||||||||
| Disulfide bond | 271 ↔ 286 | By similarity | |||||||||
| Disulfide bond | 289 ↔ 300 | By similarity | |||||||||
| Disulfide bond | 350 ↔ 363 | By similarity | |||||||||
| Disulfide bond | 357 ↔ 376 | By similarity | |||||||||
| Disulfide bond | 399 ↔ 409 | By similarity | |||||||||
| Disulfide bond | 404 ↔ 418 | By similarity | |||||||||
| Disulfide bond | 420 ↔ 429 | By similarity | |||||||||
| Disulfide bond | 436 ↔ 447 | By similarity | |||||||||
| Disulfide bond | 441 ↔ 456 | By similarity | |||||||||
| Disulfide bond | 458 ↔ 467 | By similarity | |||||||||
| Disulfide bond | 474 ↔ 500 | By similarity | |||||||||
| Disulfide bond | 527 ↔ 549 | By similarity | |||||||||
| Disulfide bond | 590 ↔ 616 | By similarity | |||||||||
| Disulfide bond | 643 ↔ 665 | By similarity | |||||||||
| Disulfide bond | 708 ↔ 734 | By similarity | |||||||||
| Disulfide bond | 761 ↔ 779 | By similarity | |||||||||
| Disulfide bond | 817 ↔ 842 | By similarity | |||||||||
| Disulfide bond | 869 ↔ 891 | By similarity | |||||||||
| Disulfide bond | 932 ↔ 958 | By similarity | |||||||||
| Disulfide bond | 985 ↔ 1005 | By similarity | |||||||||
| Disulfide bond | 1048 ↔ 1074 | By similarity | |||||||||
| Disulfide bond | 1165 ↔ 1191 | By similarity | |||||||||
| Disulfide bond | 1218 ↔ 1240 | By similarity | |||||||||
| Disulfide bond | 1278 ↔ 1306 | By similarity | |||||||||
| Disulfide bond | 1333 ↔ 1351 | By similarity | |||||||||
| Disulfide bond | 1391 ↔ 1417 | By similarity | |||||||||
| Disulfide bond | 1444 ↔ 1466 | By similarity | |||||||||
| Disulfide bond | 1510 ↔ 1536 | By similarity | |||||||||
| Disulfide bond | 1563 ↔ 1581 | By similarity | |||||||||
| Disulfide bond | 1620 ↔ 1647 | By similarity | |||||||||
| Disulfide bond | 1675 ↔ 1697 | By similarity | |||||||||
| Disulfide bond | 1738 ↔ 1764 | By similarity | |||||||||
| Disulfide bond | 1791 ↔ 1812 | By similarity | |||||||||
| Disulfide bond | 1905 ↔ 1927 | By similarity | |||||||||
| Disulfide bond | 1978 ↔ 2006 | By similarity | |||||||||
| Disulfide bond | 2032 ↔ 2054 | By similarity | |||||||||
| Disulfide bond | 2092 ↔ 2118 | By similarity | |||||||||
| Disulfide bond | 2217 ↔ 2247 | By similarity | |||||||||
| Disulfide bond | 2275 ↔ 2297 | By similarity | |||||||||
| Disulfide bond | 2336 ↔ 2363 | By similarity | |||||||||
| Disulfide bond | 2390 ↔ 2411 | By similarity | |||||||||
| Disulfide bond | 2452 ↔ 2478 | By similarity | |||||||||
| Disulfide bond | 2505 ↔ 2527 | By similarity | |||||||||
| Disulfide bond | 2570 ↔ 2599 | By similarity | |||||||||
| Disulfide bond | 2628 ↔ 2649 | By similarity | |||||||||
| Disulfide bond | 2689 ↔ 2715 | By similarity | |||||||||
| Disulfide bond | 2742 ↔ 2764 | By similarity | |||||||||
| Disulfide bond | 2805 ↔ 2831 | By similarity | |||||||||
| Disulfide bond | 2860 ↔ 2883 | By similarity | |||||||||
| Disulfide bond | 2920 ↔ 2946 | By similarity | |||||||||
| Disulfide bond | 2977 ↔ 2999 | By similarity | |||||||||
| Disulfide bond | 3037 ↔ 3064 | By similarity | |||||||||
| Disulfide bond | 3091 ↔ 3113 | By similarity | |||||||||
| Disulfide bond | 3157 ↔ 3185 | By similarity | |||||||||
| Disulfide bond | 3215 ↔ 3237 | By similarity | |||||||||
| Disulfide bond | 3278 ↔ 3306 | By similarity | |||||||||
| Disulfide bond | 3332 ↔ 3354 | By similarity | |||||||||
| Disulfide bond | 3395 ↔ 3421 | By similarity | |||||||||
| Disulfide bond | 3448 ↔ 3470 | By similarity | |||||||||
| Disulfide bond | 3511 ↔ 3537 | By similarity | |||||||||
| Disulfide bond | 3564 ↔ 3586 | By similarity | |||||||||
Experimental info | |||||||||||
| Sequence conflict | 811 – 813 | 3 | ADY → NDL AA sequence Ref.2 | ||||||||
| Sequence conflict | 819 | 1 | G → S AA sequence Ref.2 | ||||||||
| Sequence conflict | 822 – 823 | 2 | RG → QD AA sequence Ref.2 | ||||||||
| Sequence conflict | 1859 | 1 | T → Q AA sequence Ref.2 | ||||||||
| Sequence conflict | 2105 | 1 | S → P AA sequence Ref.2 | ||||||||
| Sequence conflict | 2146 – 2148 | 3 | SCS → YGA AA sequence Ref.2 | ||||||||
| Sequence conflict | 2152 | 1 | Y → L AA sequence Ref.2 | ||||||||
| Sequence conflict | 2156 | 1 | R → S AA sequence Ref.2 | ||||||||
| Sequence conflict | 2531 | 1 | N → S AA sequence Ref.2 | ||||||||
| Sequence conflict | 2536 – 2538 | 3 | FKS → WTK AA sequence Ref.2 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [2] | "Cubilin, a binding partner for galectin-3 in the murine utero-placental complex." Crider-Pirkle S., Billingsley P., Faust C., Hardy D.M., Lee V., Weitlauf H. J. Biol. Chem. 277:15904-15912(2002) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 811-823; 1849-1862; 2101-2107; 2146-2157; 2530-2538; 2545-2553 AND 3399-3407, INTERACTION WITH LGALS3, GLYCOSYLATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, FUNCTION. |
| [3] | "Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins." Hammad S.M., Barth J.L., Knaak C., Argraves W.S. J. Biol. Chem. 275:12003-12008(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2792-3623, TISSUE SPECIFICITY, INTERACTION WITH HIGH DENSITY LIPOPROTEIN, FUNCTION. Tissue: Ectoplacental cone. |
| [4] | "A two-receptor pathway for catabolism of Clara cell secretory protein in the kidney." Burmeister R., Boee I.-M., Nykjaer A., Jacobsen C., Moestrup S.K., Verroust P., Christensen E.I., Lund J., Willnow T.E. J. Biol. Chem. 276:13295-13301(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SCGB1A1, FUNCTION. |
| [5] | "Differential distribution of cubilin and megalin expression in the mouse embryo." Drake C.J., Fleming P.A., Larue A.C., Barth J.L., Chintalapudi M.R., Argraves W.S. Anat. Rec. 277:163-170(2004) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE. |
| [6] | "Mouse amnionless, which is required for primitive streak assembly, mediates cell-surface localization and endocytic function of cubilin on visceral endoderm and kidney proximal tubules." Strope S., Rivi R., Metzger T., Manova K., Lacy E. Development 131:4787-4795(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH AMN, FUNCTION. |
| [7] | "Expression and role of cubilin in the internalization of nutrients during the peri-implantation development of the rodent embryo." Assemat E., Vinot S., Gofflot F., Linsel-Nitschke P., Illien F., Chatelet F., Verroust P.J., Louvet-Vallee S., Rinninger F., Kozyraki R. Biol. Reprod. 72:1079-1086(2005) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE. |
| [8] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2085; ASN-2925 AND ASN-3125, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AL773538, AL928807 Genomic DNA. Translation: CAM15444.1. AL928807, AL773538 Genomic DNA. Translation: CAM27472.1. AF197159 mRNA. Translation: AAF61487.1. |
| IPI | IPI00124058. |
| RefSeq | NP_001074553.1. NM_001081084.2. |
| UniGene | Mm.313915. |
3D structure databases | |
| ProteinModelPortal | Q9JLB4. |
| SMR | Q9JLB4. Positions 932-1388. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9JLB4. 1 interaction. |
| MINT | MINT-4130272. |
| STRING | 10090.ENSMUSP00000089009. |
PTM databases | |
| PhosphoSite | Q9JLB4. |
Proteomic databases | |
| PaxDb | Q9JLB4. |
| PRIDE | Q9JLB4. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000091436; ENSMUSP00000089009; ENSMUSG00000026726. |
| GeneID | 65969. |
| KEGG | mmu:65969. |
| UCSC | uc008ijz.1. mouse. |
Organism-specific databases | |
| CTD | 8029. |
| MGI | MGI:1931256. Cubn. |
Phylogenomic databases | |
| eggNOG | NOG287752. |
| GeneTree | ENSGT00700000104368. |
| HOGENOM | HOG000049236. |
| HOVERGEN | HBG080357. |
| InParanoid | B1AX10. |
| KO | K14616. |
| OMA | SIQLTIH. |
| OrthoDB | EOG4J6RPX. |
Gene expression databases | |
| Bgee | Q9JLB4. |
| CleanEx | MM_CUBN. |
| Genevestigator | Q9JLB4. |
Family and domain databases | |
| Gene3D | 2.60.120.290. 27 hits. |
| InterPro | IPR000859. CUB_dom. IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR024731. EGF_dom_MSP1-like. [Graphical view] |
| Pfam | PF00431. CUB. 27 hits. PF00008. EGF. 3 hits. PF12947. EGF_3. 1 hit. PF07645. EGF_CA. 3 hits. [Graphical view] |
| SMART | SM00042. CUB. 27 hits. SM00181. EGF. 4 hits. SM00179. EGF_CA. 4 hits. [Graphical view] |
| SUPFAM | SSF49854. CUB. 27 hits. |
| PROSITE | PS00010. ASX_HYDROXYL. 3 hits. PS01180. CUB. 27 hits. PS00022. EGF_1. 4 hits. PS01186. EGF_2. 2 hits. PS50026. EGF_3. 6 hits. PS01187. EGF_CA. 4 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 320408. |
| SOURCE | Search... |
Entry information
| Entry name | CUBN_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q9JLB4 Secondary accession number(s): B1AX10 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
